Galectin-3 in Heart Failure with Preserved Ejection Fraction: A RELAX Trial Substudy

OBJECTIVE: We hypothesized that elevated Galectin-3 (Gal-3) levels would identify patients with more advanced heart failure (HF) with preserved ejection fraction (HFpEF) as assessed by key pathophysiologic domains. BACKGROUND: Gal-3 is implicated in the pathogenesis of cardiac fibrosis but is also i...

詳細記述

保存先:
書誌詳細
出版年:JACC Heart Fail
主要な著者: AbouEzzeddine, Omar F., Haines, Phillip, Stevens, Susanna, Nativi-Nicolau, Jose, Felker, G Michael, Borlaug, Barry A., Chen, Horng H., Tracy, Russell P., Braunwald, Eugene, Redfield, Margaret M.
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4369675/
https://ncbi.nlm.nih.gov/pubmed/25742762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2014.10.009
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料